查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423553

到 2030 年腦血管栓塞的市場預測：按產品、程序、最終用戶和地區進行的全球分析

Neurovascular Embolization Market Forecasts to 2030 - Global Analysis By Product, Procedure (Arteriovenous Malformation Embolization, Aneurysm Coiling and Embolization and Other Procedures), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球腦血管栓塞市場規模為 15.2 億美元，預計預測期內複合年成長率為 8.4%，到 2030 年將達到 26.7 億美元。

腦血管栓塞是一種用於治療影響大腦和神經系統血管的各種疾病的醫療程序。這涉及故意將栓塞劑（例如顆粒、線圈或液體物質）引入血管中，以阻止或減少流向用於治療異常血管結構的目標區域的血流。此外，透過阻斷或減少受影響血管的血流，腦血管栓塞可以幫助緩解症狀，防止進一步損傷，並促進整體血管穩定性。

根據腦動脈瘤基金會的數據，美國約有 670 萬人患有未破裂的腦動脈瘤，每年每 10 萬人中有 8 至 10 例破裂。

擴大醫療基礎設施

擴大醫療保健基礎設施可以促進醫療保健提供者、行業相關人員和監管機構之間的合作，並促進研究和開發舉措。這種擴展不僅可以解決神經血管疾病日益增加的負擔，而且可以及時診斷和介入。此外，協作環境支持栓塞材料、輸送系統和技術的持續改進，為整個腦血管栓塞領域的進步做出貢獻。

認知和教育有限

由於認知度低，腦血管栓塞未充分利用，患者被迫選擇替代治療。缺乏有關該程序的公眾教育宣傳活動和資訊普及導致診斷和治療的延誤。此外，腦血管栓塞很複雜，需要專門的技術來執行，這為普及造成了障礙並阻礙了市場擴張。

技術進步

栓塞劑、傳輸系統和成像技術的技術進步和創新顯著提高了腦血管栓塞的準確性、安全性和有效性。先進的輸送系統，包括微導管和導航工具，使神經干預醫生能夠到達複雜的血管結構。此外，人工智慧 (AI) 和機器學習的整合進一步完善了手術規劃和執行，最佳化結果並縮短手術時間。

經濟蕭條

景氣衰退影響接受腦血管栓塞的患者的經濟能力，常常面臨限制和成本削減措施。這可能會減少醫療程序的資金，個人在確保足夠的健康保險覆蓋方面可能面臨挑戰或資源有限。此外，景氣衰退可能會擾亂整個醫療保健生態系統，包括醫生的做法和轉診模式。醫生可能會遇到患者數量或營業額下降的情況，這阻礙了這個市場。

COVID-19 的影響

COVID-19大流行對腦血管栓塞市場產生了一些負面影響。疫情導致全球醫療保健服務中斷，涉及栓塞等某些神經血管干預措施的手術被推遲或取消，影響了整體手術量。後勤挑戰也影響了醫療設備的可得性，包括用於腦栓塞的設備。此外，不斷變化的醫療保健優先事項和醫療保健系統的財務壓力也阻礙了這個市場規模。

預計在預測期內，栓塞線圈細分市場將成為最大的細分市場

栓塞彈簧圈領域預計將佔據最大的市場佔有率，因為它專注於腦血管異常的治療。該技術涉及透過導管將鉑或其他生物相容性線圈直接放入血管中。這些線圈誘導血塊形成，促進自然癒合過程，並防止破裂的風險。此外，其在治療腦血管疾病（包括動脈瘤和動靜脈畸形）方面的多功能性，加上正在進行的研究和開發工作，正在推動該領域的擴張。

動脈瘤彈簧圈栓塞/栓塞預計在預測期內具有最高的複合年成長率

動脈瘤彈簧圈栓塞和栓塞領域預計在預測期內複合年成長率最高。動脈瘤彈簧圈栓塞是腦血管異常的重要治療方法，將導管引導穿過血管到達動脈瘤部位。然後將鉑線圈或其他栓塞裝置放入動脈瘤中，以促進血塊形成並防止破裂。此外，動脈瘤彈簧圈栓塞和栓塞侵入性較小，恢復時間較短，併發症風險較低，從而提高了醫療保健專業人員和患者的認知，這將繼續推動該市場的成長。

比最大的地區

由於需求的增加和醫療基礎設施的進步，亞太地區在預測期內佔據了最大的市場佔有率。醫療保健意識的提高、診斷能力的提高以及醫療服務獲取範圍的擴大正在推動對腦血管栓塞的需求。此外，醫療機構和行業相關人員之間的合作促進了創新栓塞材料和設備的開發和引進，推動了該地區的成長。

複合年成長率最高的地區：

由於對包括栓塞的先進介入神經放射學治療的認知不斷提高，預計歐洲在預測期內將表現出最高的複合年成長率。 Medtronic plc、Penumbra, Inc、MicroVention 和 Acandis GmbH 等主要企業繼續推動醫療保健系統的技術進步，並為改善患者治療結果做出貢獻。此外，動脈瘤和動靜脈疾病等腦血管疾病的增加正在推動該地區的擴張。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球腦血管栓塞市場：按產品

  • 分流器
  • 動脈瘤夾
  • 栓塞圈
  • 液態栓塞劑/系統
  • 其他產品

第6章全球腦血管栓塞市場：依程序

  • 動靜脈畸形（AVM）栓塞
  • 動脈瘤彈簧圈栓塞
  • 其他治療

第7章全球腦血管栓塞市場：依最終使用者分類

  • 專科診所
  • 醫院
  • 其他最終用戶

第8章全球腦栓塞市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Cerenovus
  • Penumbra Inc
  • Medtronic
  • Phenox GmbH
  • Stryker
  • Balt SAS
  • Shape Memory Medical Inc
  • Integra LifeSciences
  • B. Braun Melsungen AG
  • MicroVention Inc
  • Peter Lazic GmbH
  • Spartan Micro
Product Code: SMRC24787

According to Stratistics MRC, the Global Neurovascular Embolization Market is accounted for $1.52 billion in 2023 and is expected to reach $2.67 billion by 2030 growing at a CAGR of 8.4% during the forecast period. Neurovascular embolization is a medical procedure used to treat various conditions affecting the blood vessels of the brain and nervous system. It involves the intentional introduction of embolic agents, such as particles, coils, or liquid substances, into the blood vessels to block or reduce blood flow to targeted areas employed to treat abnormal vascular structures. Furthermore, by occluding or reducing blood flow to the affected vessels, neurovascular embolization helps to alleviate symptoms, prevent further damage, and promote overall vascular stability.

According to the Brain Aneurysms Foundation, in the U.S., roughly 6.7 million people have unruptured brain aneurysms, leading to an annual rupture rate of 8-10 cases per 100,000.

Market Dynamics:

Driver:

Expansion of Healthcare Infrastructure

The expansion of healthcare infrastructure facilitates collaborative efforts between healthcare institutions, industry stakeholders, and regulatory bodies, fostering research and development initiatives. This expansion not only addresses the growing burden of neurovascular disorders but also enables timely diagnosis and intervention. Moreover, a collaborative environment supports the continuous improvement of embolic materials, delivery systems, and procedural techniques, contributing to the overall advancement of the neurovascular embolization field.

Restraint:

Limited awareness and education

The limited awareness can lead to underutilization of neurovascular embolization, with patients being directed towards alternative treatments. Lack of public education campaigns and information dissemination about the procedure can result in delayed diagnosis and treatment. Furthermore, the complexity of neurovascular embolization and the specialized skills required to perform the procedure can be a barrier to its widespread adoption, which is impeding this market expansion.

Opportunity:

Technological advancements

The advancements in technology and innovations in embolic materials, delivery systems, and imaging technologies have significantly improved the precision, safety, and efficacy of neurovascular embolization procedures. Advanced delivery systems, including microcatheters and navigation tools, enable neurointerventionalists to reach intricate vascular structures. Furthermore, the integration of artificial intelligence (AI) and machine learning further refines procedural planning and execution, optimizing outcomes and reducing procedural times, which drive this market growth.

Threat:

Economic downturns

Economic downturns impact patients' ability to afford neurovascular embolization procedures and often face constraints and cost-cutting measures. This can lead to a reduction in funding for medical procedures, and individuals may face challenges in securing adequate health insurance coverage or may have limited resources. Additionally, economic downturns can disrupt the overall healthcare ecosystem, including physician practices and referral patterns. Physicians may experience reduced patient volumes or changes, which are hampering this market.

Covid-19 Impact

The COVID-19 pandemic has had several negative impacts on the neurovascular embolization market. The pandemic led to disruptions in healthcare services globally, procedures including certain neurovascular interventions like embolization, which were deferred or cancelled, impacting the overall procedural volume. Logistic challenges also impacted the availability of medical devices, including those used in neurovascular embolization. In addition, the shift in healthcare priorities and the financial strain on healthcare systems also hindered this market size.

The embolic coils segment is expected to be the largest during the forecast period

The embolic coil segment is estimated to hold the largest share due to its focus on the treatment of vascular abnormalities in the brain. This technique involves the deployment of platinum or other biocompatible coils through a catheter directly into the blood vessel. These coils induce clot formation, promoting the natural healing process and preventing the risk of rupture. In addition, it is versatile in treating cerebrovascular conditions, including aneurysms and arteriovenous malformations, coupled with ongoing research and development efforts that are boosting this segment's expansion.

The aneurysm coiling and embolization segment is expected to have the highest CAGR during the forecast period

The aneurysm coiling and embolization segment is anticipated to have highest CAGR during the forecast period. It is a crucial intervention for treating vascular abnormalities in the brain, wherein a catheter is navigated through blood vessels to the site of the aneurysm. Platinum coils or other embolic devices are then deployed into the aneurysm, promoting blood clot formation and preventing rupture. Furthermore, aneurysm coiling and embolization procedures offer reduced invasiveness, shorter recovery times, and a lower risk of complications, and rising awareness among both healthcare providers and patients contributes to the sustained growth of this market.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period, owing to increased demand and advancements in healthcare infrastructure. Increasing healthcare awareness, improved diagnostic capabilities, and expanding access to healthcare services have heightened the demand for neurovascular embolization procedures. Furthermore, collaborative efforts between healthcare institutions and industry players have resulted in the development and introduction of innovative embolic materials and devices, which are driving this region's growth.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to a growing awareness of advanced neurointerventional procedures, including embolization. Key players such as Medtronic plc, Penumbra, Inc., MicroVention, and Acandis GmbH continue to evolve technological advancements in healthcare systems, contributing to improved patient outcomes. Furthermore, increasing incidences of cerebrovascular diseases, such as aneurysms and arteriovenous, are propelling this region's expansion.

Key players in the market

Some of the key players in the Neurovascular Embolization Market include Cerenovus, Penumbra Inc, Medtronic, Phenox GmbH, Stryker, Balt SAS, Shape Memory Medical Inc, Integra LifeSciences, B. Braun Melsungen AG, MicroVention Inc, Peter Lazic GmbH and Spartan Micro.

Key Developments:

In August 2023, Medtronic announced the outcome of the U.S. Food & Drug Administration (FDA) Circulatory System Devices Panel (CSDP) meeting to review data presented in support of the Medtronic Symplicity Spyral™ Renal Denervation (RDN) System.

In February 2022, CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices Companies,* announced the launch of EMBOGUARD™, a next generation balloon guide catheter to be used in endovascular procedures, including those for patients with acute ischemic stroke.

In June 2021, Johnson & Johnson Medical Devices Companies* announced the first patient was enrolled in the CERENOVUS-sponsored MEMBRANE study evaluating TruFill® n-BCA Liquid Embolic System in the embolization of middle meningeal artery (MMA) for treatment of chronic subdural hematoma (cSDH) as adjunct to surgical evacuation or as a stand-alone treatment.

In January 2020, MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neurovascular company announced the FDA Premarket Approval (PMA) for the FRED® (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms.

Products Covered:

  • Flow Diversion Devices
  • Aneurysm Clips
  • Embolic Coils
  • Liquid Embolic Agents/Systems
  • Other Products

Procedures Covered:

  • Arteriovenous Malformation (AVM) Embolization
  • Aneurysm Coiling and Embolization
  • Other Procedures

End Users Covered:

  • Specialty Clinics
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurovascular Embolization Market, By Product

  • 5.1 Introduction
  • 5.2 Flow Diversion Devices
  • 5.3 Aneurysm Clips
  • 5.4 Embolic Coils
  • 5.5 Liquid Embolic Agents/Systems
  • 5.6 Other Products

6 Global Neurovascular Embolization Market, By Procedure

  • 6.1 Introduction
  • 6.2 Arteriovenous Malformation (AVM) Embolization
  • 6.3 Aneurysm Coiling and Embolization
  • 6.4 Other Procedures

7 Global Neurovascular Embolization Market, By End User

  • 7.1 Introduction
  • 7.2 Specialty Clinics
  • 7.3 Hospitals
  • 7.4 Other End Users

8 Global Neurovascular Embolization Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Cerenovus
  • 10.2 Penumbra Inc
  • 10.3 Medtronic
  • 10.4 Phenox GmbH
  • 10.5 Stryker
  • 10.6 Balt SAS
  • 10.7 Shape Memory Medical Inc
  • 10.8 Integra LifeSciences
  • 10.9 B. Braun Melsungen AG
  • 10.10 MicroVention Inc
  • 10.11 Peter Lazic GmbH
  • 10.12 Spartan Micro

List of Tables

  • Table 1 Global Neurovascular Embolization Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
  • Table 4 Global Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
  • Table 5 Global Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
  • Table 6 Global Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
  • Table 7 Global Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 8 Global Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 9 Global Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
  • Table 10 Global Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
  • Table 11 Global Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
  • Table 12 Global Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
  • Table 13 Global Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 14 Global Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 15 Global Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 16 North America Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
  • Table 17 North America Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
  • Table 18 North America Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
  • Table 19 North America Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
  • Table 20 North America Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
  • Table 21 North America Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
  • Table 22 North America Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 23 North America Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 24 North America Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
  • Table 25 North America Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
  • Table 26 North America Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
  • Table 27 North America Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
  • Table 28 North America Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 29 North America Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 30 North America Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 31 Europe Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
  • Table 32 Europe Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
  • Table 33 Europe Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
  • Table 34 Europe Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
  • Table 35 Europe Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
  • Table 36 Europe Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
  • Table 37 Europe Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 38 Europe Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 39 Europe Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
  • Table 40 Europe Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
  • Table 41 Europe Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
  • Table 42 Europe Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
  • Table 43 Europe Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 44 Europe Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 45 Europe Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 46 Asia Pacific Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
  • Table 47 Asia Pacific Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
  • Table 48 Asia Pacific Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
  • Table 49 Asia Pacific Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
  • Table 50 Asia Pacific Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
  • Table 51 Asia Pacific Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
  • Table 52 Asia Pacific Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 53 Asia Pacific Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 54 Asia Pacific Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
  • Table 55 Asia Pacific Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
  • Table 56 Asia Pacific Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
  • Table 57 Asia Pacific Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
  • Table 58 Asia Pacific Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 59 Asia Pacific Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 60 Asia Pacific Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 61 South America Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 South America Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
  • Table 63 South America Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
  • Table 64 South America Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
  • Table 65 South America Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
  • Table 66 South America Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
  • Table 67 South America Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 68 South America Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 69 South America Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
  • Table 70 South America Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
  • Table 71 South America Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
  • Table 72 South America Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
  • Table 73 South America Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 74 South America Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 75 South America Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 76 Middle East & Africa Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
  • Table 77 Middle East & Africa Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
  • Table 78 Middle East & Africa Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
  • Table 79 Middle East & Africa Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
  • Table 80 Middle East & Africa Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
  • Table 81 Middle East & Africa Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
  • Table 82 Middle East & Africa Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 83 Middle East & Africa Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 84 Middle East & Africa Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
  • Table 85 Middle East & Africa Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
  • Table 86 Middle East & Africa Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
  • Table 87 Middle East & Africa Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
  • Table 88 Middle East & Africa Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 89 Middle East & Africa Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 90 Middle East & Africa Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)